n(g),n(g')-dimethyl-l-arginine has been researched along with cardiovascular agents in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (50.00) | 29.6817 |
2010's | 6 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cooke, JP; Weis, M | 1 |
Bae, SW; Choi, BY; Choi, YH; Lee, SH; Lee, YS; Pachinger, O; Park, HK; Park, JE; Stühlinger, MC; Yoo, HS; Yu, KH | 1 |
Ambrose, J; Bernaski, E; Coppola, J; El-Khally, Z; Kurian, D; Mandadi, V; Morlote, M; Pinassi, E; Staniloae, C | 1 |
Hu, CP; Huang, H; Jia, SJ; Jiang, DJ; Jiang, JL; Li, YJ; Tan, B | 1 |
Mangoni, AA; Wadham, C | 1 |
Coppola, JT; Deshmukh, SH; Hermance, EV; Infantino, MN; Mindrescu, C; Patel, SR; Pinassi, E; Staniloae, CS | 1 |
Bucciarelli, T; D'Orazio, N; Felaco, M; Franceschelli, S; Gaeta, R; Grilli, A; Riccioni, G; Speranza, L | 1 |
Caplin, B; Leiper, J | 1 |
Borzak, S; DeMets, D; Hennekens, CH; Hetzel, S; Schneider, R; Schneider, W; Schröder, H; Serebruany, V | 1 |
Okuda, S; Ueda, S; Yamagishi, S; Yokoro, M | 1 |
He, GW; Liu, Z; Lun, LM; Ning, CP; Wang, HW; Wang, J; Xuan, C; Zhang, BB; Zhao, JX | 1 |
Chen, HW; Feng, J; Pi, LJ; Wang, J; Zhan, DQ | 1 |
4 review(s) available for n(g),n(g')-dimethyl-l-arginine and cardiovascular agents
Article | Year |
---|---|
Cardiac allograft vasculopathy and dysregulation of the NO synthase pathway.
Topics: Animals; Arginine; Cardiovascular Agents; Coronary Artery Disease; Endothelium, Vascular; Graft Rejection; Heart Transplantation; Humans; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Postoperative Complications; Rabbits; Transplantation, Homologous; Vasodilation; Vasomotor System | 2003 |
Dimethylarginine dimethylaminohydrolase regulation: a novel therapeutic target in cardiovascular disease.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Agents; Cardiovascular Diseases; Disease Progression; Drug Delivery Systems; Gene Expression Regulation, Enzymologic; Humans; Nitric Oxide | 2009 |
Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?
Topics: Amidohydrolases; Animals; Arginine; Binding Sites; Binding, Competitive; Biomarkers; Cardiovascular Agents; Cardiovascular Diseases; Catalytic Domain; Enzyme Inhibitors; Humans; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine | 2012 |
Role of asymmetric dimethylarginine in cardiorenal syndrome.
Topics: Animals; Arginine; Cardio-Renal Syndrome; Cardiovascular Agents; Drug Delivery Systems; Humans; Nitric Oxide Synthase | 2014 |
3 trial(s) available for n(g),n(g')-dimethyl-l-arginine and cardiovascular agents
Article | Year |
---|---|
Pioglitazone improves endothelial function in non-diabetic patients with coronary artery disease.
Topics: Adult; Aged; Arginine; Blood Sedimentation; Brachial Artery; C-Reactive Protein; Cardiovascular Agents; Coronary Artery Disease; Endothelium, Vascular; Fibrinogen; Humans; Lipids; Male; Middle Aged; Pioglitazone; PPAR gamma; Prospective Studies; Thiazolidinediones | 2007 |
Ranolazine improves endothelial function in patients with stable coronary artery disease.
Topics: Acetanilides; Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Agents; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hyperemia; Inflammation Mediators; Male; Manometry; Middle Aged; Piperazines; Ranolazine; Time Factors; Treatment Outcome; Vasodilation | 2009 |
Aspirin increases nitric oxide formation in chronic stable coronary disease.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Aspirin; Biomarkers; Cardiovascular Agents; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Down-Regulation; Female; Heme Oxygenase-1; Humans; Male; Middle Aged; Nitric Oxide; Platelet Aggregation Inhibitors; Tablets, Enteric-Coated; Up-Regulation | 2013 |
5 other study(ies) available for n(g),n(g')-dimethyl-l-arginine and cardiovascular agents
Article | Year |
---|---|
Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment.
Topics: Adult; Aged; alpha-Tocopherol; Angina, Unstable; Angioplasty, Balloon, Coronary; Arginine; C-Reactive Protein; Cardiovascular Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Combined Modality Therapy; Coronary Angiography; Coronary Artery Disease; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Insulin; Lipoproteins, HDL; Male; Middle Aged; Myocardial Infarction; Statistics as Topic; Treatment Outcome; Triglycerides | 2005 |
Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
Topics: Acetylcholine; Amidohydrolases; Animals; Arginine; Cardiovascular Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Nitric Oxide; Rats; Rats, Sprague-Dawley; Taurine; Time Factors; Tumor Necrosis Factor-alpha; Vasodilation; Vasodilator Agents; Vitamin E | 2007 |
The biological effect of pharmacological treatment on dimethylaminohydrolases (DDAH-1) and cationic amino acid transporter-1 (CAT-1) expression in patients with acute congestive heart failure.
Topics: Acute Disease; Aged; Amidohydrolases; Arginine; Cardiovascular Agents; Cationic Amino Acid Transporter 1; Chromatography, High Pressure Liquid; Echocardiography, Doppler; Female; Heart Failure; Humans; Italy; Male; Middle Aged; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2011 |
L-citrulline for protection of endothelial function from ADMA-induced injury in porcine coronary artery.
Topics: Animals; Arginine; Cardiovascular Agents; Citrulline; Coronary Vessels; Cyclic GMP; Drug Evaluation, Preclinical; Endothelium, Vascular; Nitric Oxide Synthase Type III; Phosphorylation; Protein Processing, Post-Translational; Superoxides; Sus scrofa; Vascular System Injuries | 2015 |
Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway.
Topics: Abietanes; Animals; Arginine; Cardiomegaly; Cardiovascular Agents; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Cystatin C; Disease Models, Animal; Hypertension; Male; Myocardium; NADPH Oxidase 4; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Troponin I; Wnt Signaling Pathway | 2017 |